Six-month study demonstrates 85% symptom reduction and strong safety profile, advancing a minimally invasive solution for urgency urinary incontinence treatment. ...
The initiative strengthens opioid prevention across Alabama by providing communities with vital education and at-home medication disposal solutions to reduce misuse and accidental overdoses....
The collaboration enhances Esco's IVF instrument portfolio with Allwin's consumables, offering a comprehensive solution for IVF clinicians and embryologists while expanding market presence in India....
New real-time, self-adjusting deep brain stimulation system transforms Parkinson’s care with personalized neuromodulation...
Regulatory green light follows IMROZ Phase 3 study results showing significant progression-free survival benefit...
The new 2 mL pre-filled pen option expands individualized treatment choices for hereditary angioedema (HAE) patients, reinforcing Takeda’s commitment to reducing disease burden and improving quality of life....
Building on FDA clearance, IceCure files for Israeli approval of its XSense™ System, expanding minimally invasive cryoablation solutions across multiple medical specialties in line with the growing trend of surgical de-escalation. ...
Following constructive discussions with the FDA, Co-Dx shifts focus to an improved test submission, incorporating platform advancements and optimizing long-term performance....
In collaboration with HaDEA and HERA, Ginkgo leads the RANGER project to create a point-of-care metagenomic sequencing device, aiming for 6-hour turnaround diagnostics to revolutionize pandemic preparedness and hospital triage across Europe. ...
With all female patients in its groundbreaking clinical feasibility study reaching six-month primary endpoints, UroMems' UroActive System marks a transformative step in treating stress urinary incontinence. The AI-powered smart implant, designed to enhance patient quality of life, is now paving the way for expanded adoption in the U.S. and Europe. ...
